CRSP
HEALTHCARECRISPR Therapeutics AG
$55.08+2.70 (+5.15%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving CRSP Today?
No stock-specific AI insight has been generated for CRSP yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$34.87$78.48
$55.08
Fundamentals
Market Cap$5.3B
P/E Ratio—
EPS$-6.17
Dividend Yield—
Dividend / Share—
ROE-0.3%
Profit Margin—
Debt / Equity—
Trading
Volume2.5M
Avg Volume (10D)—
Shares Outstanding96.4M
CRSP News
25 articles- VRTX's Alyftrek, Journavx & Casgevy See Strong Momentum in Q1 EarningsYahoo Finance·May 8, 2026
- CRISPR Therapeutics AG (CRSP) Is a Trending Stock: Facts to Know Before Betting on ItYahoo Finance·May 8, 2026
- Is It Time To Reconsider CRISPR Therapeutics (CRSP) After A 58% One Year Rally?Yahoo Finance·May 6, 2026
- CRISPR Therapeutics to Present at the Bank of America Securities 2026 Global Healthcare ConferenceYahoo Finance·May 6, 2026
- Is This Millionaire-Maker Biotech Stock a Buy Right Now?The Motley Fool·May 6, 2026
- VRTX's Q1 Earnings Beat Estimates, New Products Aid Sales GrowthYahoo Finance·May 5, 2026
- CRISPR Therapeutics' Q1 Loss Wider Than Expected, Sales Miss EstimatesYahoo Finance·May 5, 2026
- CRISPR Therapeutics AG (CRSP) Reports Q1 Loss, Lags Revenue EstimatesYahoo Finance·May 4, 2026
- CRISPR Therapeutics Provides Business Update and Reports First Quarter 2026 Financial ResultsYahoo Finance·May 4, 2026
- What's the Next Big Thing After GLP-1 Drugs? CRISPR Therapeutics May Have the Answer.Motley Fool·Apr 30, 2026
- Why CRISPR Therapeutics (CRSP) Is Down 10.1% After Casgevy’s Strong Early Launch Metrics And Earnings HopesYahoo Finance·Apr 29, 2026
- CRISPR Therapeutics AG (CRSP) Dips More Than Broader Market: What You Should KnowYahoo Finance·Apr 29, 2026
- 3 Growth Stocks That Could Generate 10X ReturnsMotley Fool·Apr 29, 2026
- Mirum Pharmaceuticals, Inc. (MIRM) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 ReleaseYahoo Finance·Apr 29, 2026
- Why the Market Dipped But CRISPR Therapeutics AG (CRSP) Gained TodayYahoo Finance·Apr 28, 2026
- Vertex Gears Up to Report Q1 Earnings: What Investors Can ExpectYahoo Finance·Apr 28, 2026
- CRISPR Therapeutics AG (CRSP) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 ReleaseYahoo Finance·Apr 28, 2026
- CRISPR Therapeutics to Report Q1 Earnings: Is a Beat in the Cards?Yahoo Finance·Apr 27, 2026
- 3 Biotech Stocks That Could Benefit from the Patent CliffMarketbeat·Apr 27, 2026
- Cathie Wood Is Loading Up on These 3 Next-Gen Tech Stocks247 Wall St·Apr 23, 2026
- CRISPR Therapeutics AG (CRSP) Rises Higher Than Market: Key FactsYahoo Finance·Apr 22, 2026
- CRISPR Therapeutics Has Major Catalysts Ahead. Is This Biotech Stock a Screaming Buy?The Motley Fool·Apr 21, 2026
- 2 Billion Reasons to Love CRISPR Therapeutics Right NowThe Motley Fool·Apr 13, 2026
- This Biotech Has a Pipeline That Could Redefine Its Entire Therapeutic AreaThe Motley Fool·Apr 8, 2026
- Anti-Aging Protein Research Takes a Step Forward with Cell CloningBenzinga·Mar 24, 2026
All 25 articles loaded
Price Data
Open$53.00
Previous Close$52.38
Day High$55.40
Day Low$52.65
52 Week High$78.48
52 Week Low$34.87
52-Week Range
$34.87$78.48
$55.08
Fundamentals
Market Cap$5.3B
P/E Ratio—
EPS$-6.17
Dividend Yield—
Dividend / Share—
ROE-0.3%
Profit Margin—
Debt / Equity—
Trading
Volume2.5M
Avg Volume (10D)—
Shares Outstanding96.4M
About CRISPR Therapeutics AG
CRISPR Therapeutics AG, a gene editing company, focuses on the development of gene-based transformative drugs for serious human diseases. The company is headquartered in Zug, Switzerland.
HEALTHCAREBIOTECHNOLOGY
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICBIOTECHNOLOGY
CIK—
Composite FIGI—
Share Class FIGI—